Daniel Schneiderman

Daniel Schneiderman

Director of Finance/CFO at PASITHEA THERAPEUTICS CORP.

Net worth: - $ as of 31/03/2024

46 year
Health Technology
Finance
Consumer Services

Profile

Daniel H.
Schneiderman
is currently the Chief Financial Officer at Pasithea Therapeutics Corp.
He previously held positions as Director at Unleashed Ny from 1996 to 2000, Vice President-Investment Banking at Burnham Hill Partners LLC from 2004 to 2012, Secretary, Vice President-Finance & Controller at MetaStat, Inc. from 2012 to 2018, Chief Financial Officer at Biophytis SA in 2018-2019, and Chief Financial Officer at First Wave Biopharma, Inc. from 2020 to 2022.
He also served as Chief Financial Officer at Biophytis, Inc. Mr. Schneiderman received an undergraduate degree from Tulane University (Louisiana).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/03/2024 0 ( -.--% ) - $ 31/03/2024

Daniel Schneiderman active positions

CompaniesPositionStart
PASITHEA THERAPEUTICS CORP. Director of Finance/CFO 11/10/2022
All active positions of Daniel Schneiderman

Former positions of Daniel Schneiderman

CompaniesPositionEnd
FIRST WAVE BIOPHARMA, INC. Director of Finance/CFO 28/02/2022
BIOPHYTIS S.A. Director of Finance/CFO 01/12/2019
METASTAT, INC. Comptroller/Controller/Auditor 01/08/2018
Corporate Officer/Principal 01/01/2012
Unleashed Ny Director/Board Member 01/01/2000
See the detail of Daniel Schneiderman's experience

Training of Daniel Schneiderman

Tulane University (Louisiana) Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Schneiderman's experience

Connections

36

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
BIOPHYTIS S.A.

Health Technology

METASTAT, INC.

Producer Manufacturing

FIRST WAVE BIOPHARMA, INC.

Health Technology

Private companies4

Finance

Unleashed Ny

Health Technology

Pasithea Therapeutics Corp.

See company connections
  1. Stock Market
  2. Insiders
  3. Daniel Schneiderman
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW